Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements are key therapeutic targets for biomarker-driven treatment with an EGFR or ALK tyrosine kinase inhibitor (TKI) in patients with metastatic non-small cell lung cancer (NSCLC). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinde, Reshma, Cao, Xiting, Kothari, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397943/
https://www.ncbi.nlm.nih.gov/pubmed/27668568
http://dx.doi.org/10.18553/jmcp.2016.15404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397943/
https://www.ncbi.nlm.nih.gov/pubmed/27668568
http://dx.doi.org/10.18553/jmcp.2016.15404

Ejemplares similares